W
WAVEMAN · COMPANY
SERA · Sera Prognostics, Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475
← ALL COMPANIES

SERA

SERA PROGNOSTICS, INC.
HEALTHCARE SERVICES · SERVICES-MEDICAL LABORATORIES · CIK 0001534969
SEC FILINGS☆ WATCH
INSIDER NET · 180D
-$186.7K
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
12
13F, latest reported quarter
REVENUE GROWTH
+5.2%
XBRL, annual
NET MARGIN
-
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$186.7K over 180 days
-$90.6K over 90 days
more than 63% of Healthcare Services
CONGRESS
no member of Congress has reported trading it
FUNDS
12 funds added or opened last quarter
below 90% of Healthcare Services
REVENUE
+5.2% year over year
below 65% of Healthcare Services
MARGIN
no margin: this company reports no revenue to divide by
BUYBACKS
no share repurchases reported
SHORT
no short interest reported
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
Insiders are net sellers: -$186.7K across 9 people in 180 days.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN -39.6%
-39.6%12M
-52%-31%-9%+13%2025-092025-102025-122026-032026-052026-072026-09 2025-12-02 · Kearney Paul sold $94.7K2025-12-09 · Lindgardt Zhenya sold $85.8K2025-09-09 · Lindgardt Zhenya sold $66.6K2026-06-09 · Lindgardt Zhenya sold $43.2K2026-03-10 · Lindgardt Zhenya sold $43.0K2025-11-10 · Lindgardt Zhenya sold $30.4K2025-11-10 · Boniface John J. sold $20.3K2025-11-10 · Kearney Paul sold $18.5K2025-11-10 · Jackson Benjamin sold $18.5K2025-11-10 · Harrison Robert Gardner sold $17.1K2025-11-10 · Aerts Austin sold $16.6K2025-09-09 · Aerts Austin sold $16.6K2025-12-09 · Aerts Austin sold $15.9K2026-06-11 · Lindgardt Zhenya sold $14.0K2025-12-10 · Lindgardt Zhenya sold $13.8K2025-09-09 · Lawrence Sandra AJ sold $11.9K2026-03-10 · Aerts Austin sold $11.5K2026-06-09 · Aerts Austin sold $11.3K2025-09-11 · Lindgardt Zhenya sold $10.2K2026-06-11 · Anderson Dyaarl Lee Jr. sold $9.5K2025-11-26 · Kearney Paul sold $7.0K2026-03-09 · Harrison Robert Gardner sold $6.6K2025-10-07 · Harrison Robert Gardner sold $6.4K2025-11-04 · Harrison Robert Gardner sold $6.1K2026-03-09 · Jackson Benjamin sold $6.1K2025-09-09 · Harrison Robert Gardner sold $6.1K2026-03-11 · Lindgardt Zhenya sold $6.1K2025-12-30 · Harrison Robert Gardner sold $6.0K2026-03-09 · Boniface John J. sold $6.0K2026-01-27 · Harrison Robert Gardner sold $5.9K2025-12-02 · Harrison Robert Gardner sold $5.9K2025-09-02 · Kearney Paul sold $5.1K2025-12-08 · Lawrence Sandra AJ sold $4.8K2025-09-09 · Lawrence Sandra AJ sold $4.8K2026-02-24 · Harrison Robert Gardner sold $4.7K2025-12-10 · Boniface John J. sold $4.4K2026-06-11 · Jackson Benjamin sold $4.4K2025-09-11 · Boniface John J. sold $4.4K2026-06-11 · Aerts Austin sold $4.1K2025-12-10 · Kearney Paul sold $4.0K2025-09-11 · Kearney Paul sold $4.0K2026-03-09 · Kearney Paul sold $4.0K
INSIDER SELL
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
The complete filing record, in one place.
The record shows a net $186.7K sold by insiders over 180 days, 12 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
NTRACSTLPGNYHIMSWGSPRVATDOCAVAHGHADUSBDSXENSG
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, SERA PROGNOSTICS, INC. insiders sold a net $186.7K of stock across 210 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER
FILED
SHARES
VALUE
Anderson Dyaarl Lee Jr.
Chief Commercial Officer
SELL
2026-06-11
4,739.0
$9.5K
Aerts Austin
Chief Financial Officer
SELL
2026-06-11
2,037.0
$4.1K
Lindgardt Zhenya
Chief Executive Officer
SELL
2026-06-11
6,990.0
$14.0K
Inglis Tiffany Eul Davis
Chief Medical Officer
SELL
2026-06-11
362.0
$728
Jackson Benjamin
General Counsel
SELL
2026-06-11
2,179.0
$4.4K
210 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 205 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
BAKER BROS. ADVISORS LP
5,498,170.0 sh
$10.0M
Whetstone Capital Advisors, LLC
3,306,889.0 sh
$6.0M
Aberdeen Group plc
2,753,525.0 sh
$5.0M
Vivo Capital, LLC
1,650,440.0 sh
$3.0M
VANGUARD CAPITAL MANAGEMENT LLC
1,297,792.0 sh
$2.4M
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Ultra-Small Company Market Fund
$83.4K POSITION · AS OF 2026-03-31
0.1%
iShares Micro-Cap ETF
$160.8K POSITION · AS OF 2026-03-31
0.0%
1290 VT Micro Cap Portfolio
$10.9K POSITION · AS OF 2026-03-31
0.0%
Small Cap Core Fund
$20.9K POSITION · AS OF 2026-03-31
0.0%
JNL/DFA U.S. Small Cap Fund
$6.7K POSITION · AS OF 2026-03-31
0.0%
Fidelity Extended Market Index Fund
$367.4K POSITION · AS OF 2026-02-28
0.0%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Clinical pipeline
ClinicalTrials.gov · 1 registered trials, 1 still enrolling or running — a status change here is dated weeks before the press release
1
Not applicable
1 ACTIVE
TRIALS MATCHED TO THIS TICKER BY SPONSOR NAME · STUDIES RUN UNDER A SUBSIDIARY'S OWN NAME ARE NOT INCLUDED
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$81.0K$77.0K$306.0K$268.0K
OPERATING INCOME$-36.5M$-36.6M$-39.8M$-45.7M
NET INCOME$-31.9M$-32.9M$-36.2M$-44.2M
EPS (DILUTED)-0.67-0.99-1.16-1.43
OPERATING CASH FLOW$-25.6M$-14.2M$-27.2M$-34.6M
CASH$3.9M$4.0M$3.9M$29.9M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
PRODUCT
DeskBacktester CompaniesAccount
SUPPORT
FAQMethodology Contact
LEGAL
TermsPrivacy Accessibility
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-05 ALL SYSTEMS LIVE FOR MACHINES →